CONTACT
Image 43@2x
News

BioPharma Trend: A new way to work with data in life sciences

Interview with Marilyn Matz, CEO and Co-founder at Paradigm4, and 2020 NACD Directorship 100™ honoree, and her colleague Dr. Zachary Pitluk, VP of Life Sciences and Health Care at Paradigm4.

Founded by renowned database researcher, Turing Award laureate MIT Professor Michael Stonebraker, Paradigm4 is not just any data analytics company in the Life Sciences. The organization is built on the decades of pioneering research in database design and possesses unique technological know-how in scientific data management and scalable computation.

READ FULL ARTICLE

  • Related News & Events
whitepages icon x

Biocompare || Introduction to Spatial Metabolomics

Metabolomics—often referred to as the youngest of the omics—provides key insight into phenotype. However, bulk metabolomics requires the homogenization of the sample and is thus unable to discern metabolic differences at a cellular level.

whitepages icon x

BIO-IT World | Is Precision Medicine Ready For Data From Billions Of Cells?

Popular opinion is that two big shifts have changed the game for bioinformatics. The first is a technology development—single cell ‘omics—that began just over 10 years ago, the other is a more recent move to a new model of drug discovery that looks to leverage the vast amounts of human

whitepages icon x

Eurolab || Intelligent Design

Dr. Zach Pitluk and Dr. Srikant Sarangi on preparing the way for AI/ML to impact drug discovery and development.

Group 14683
Group 90
Image 43@2x
Solutions
Why P4?
Resources
About
  • © Paradigm4, 281 Winter St. Suite 360 Waltham, MA 02451
|  Privacy Policy  |  Terms of Use
CONTACT